A case of probable Vogt–Koyanagi–Harada disease in a 3-year-old girl

• Main Authors: Atsuko Katsuyama, Sentaro Kusuhara, Hiroyuki Awano, Hiroaki Nagase, Wataru Matsumiya, Makoto Nakamura
• Format: Article
• Language: English
• Published: BMC 2019-08-01
• Series: BMC Ophthalmology
• Subjects: Vogt–Koyanagi–Harada disease; Child; Uveitis; Corticosteroid therapy
• Online Access: http://link.springer.com/article/10.1186/s12886-019-1192-0

Abstract Background Vogt–Koyanagi–Harada (VKH) disease is a T-cell-mediated autoimmune disorder characterized by bilateral granulomatous panuveitis with various systemic manifestations. Although VKH disease rarely occurs in the pediatric population, the clinical course tends to be aggressive, and the visual prognosis is worse than that in adult patients due to severe ocular complications secondary to recurrent inflammation. Case presentation A 3-year-old girl with probable VKH was referred to Kobe University Hospital. She had severe bilateral panuveitis with posterior synechiae of the iris, marked optic disk swelling, and serous retinal detachment in both eyes, and her best corrected visual acuities (BCVAs) were 20/200 OD and 20/125 OS. A third course of therapy was administered because serous retinal detachment remained after two courses of therapy. She was treated with three courses of high-dose intravenous corticosteroid therapy, followed by slow tapering of oral corticosteroids. Her BCVAs recovered to 20/16 OU, and relapse of ocular inflammation and side effect of treatment were not observed during the 1.5-year follow-up period. Conclusions We experienced a pediatric patient with probable VKH disease who was treated with three courses of high-dose intravenous corticosteroid therapy. With the favorable clinical course in our patient, initial treatment with repeated high-dose intravenous corticosteroid therapy might be beneficial in pediatric VKH disease.